Epilepsy drug, modified by CU professor, reaches first clinical trial

A professor at the University of Colorado Skaggs School of Pharmacy, Tom Anchordoquy, PhD, and Dan Abrams, MD and CEO of Cerebral Therapeutics, have modified an epilepsy drug and changed the way it’s delivered to better the lives of these patients. It is in a clinical trial right now.
Published: 4:16 PM MDT June 13, 2019